Overview
About Shermox-D
Shermox-D extends the Shermox family with combination support where infection and inflammation are clinically considered together. It is positioned for ophthalmologist-directed use within appropriate infectious care pathways.
Key highlights
- Combination approach within the Shermox range
- Supports infection-linked inflammatory presentations
- Aligned with evidence-based prescribing practice
Medical & Partnerships
Need more on Shermox-D?
Our team can share scientific support, availability, and partnership details for ophthalmologists and healthcare partners.